A Multidisciplinary Approach to Improve the Management of Immune-Checkpoint Inhibitor-Related Pneumonitis
Im-PN is a rare but challenging side effect of ICI therapy, with variable time of onset and with heterogeneous clinical and radiological presentations. A multidisciplinary assessment is mandatory to optimize the clinical management of im-PN.
Authors
- Claudia Ghiribelli
- Raffaella Guazzo
- Luana Calabrò (ORCID: https://orcid.org/0000-0002-3044-0889)
- Maura Colucci (ORCID: https://orcid.org/0000-0003-4069-9330)
- Michele Maio (ORCID: https://orcid.org/0000-0002-0323-6321)
- Virginia Vegni
- Anna Maria Di Giacomo (ORCID: https://orcid.org/0000-0001-9315-2158)
- Elena Simonetti (ORCID: https://orcid.org/0009-0000-9647-4662)
- Elena Bargagli (ORCID: https://orcid.org/0000-0002-8351-3703)
- Cristiana Bellan (ORCID: https://orcid.org/0000-0001-6119-9007)
- Vinno Savelli (ORCID: https://orcid.org/0000-0001-7497-3831)
- Matteo Ravara
- Monica Valente (ORCID: https://orcid.org/0000-0002-6031-9916)
- Tommaso Sani
- Giulia Rossi
- Valentina Croce
- Francesco Frongia
- G Gibilisco
Institutions
- University of Siena (IT)
- University of Ferrara (IT)
- Network Italiano Per la Bioterapia Dei Tumori (IT)
- Toscana Life Sciences (IT)
Publication Details
- Journal
- OncoTargets and Therapy
- Published
- 2024-08-01
- DOI
- https://doi.org/10.2147/ott.s470892
- Citations
- 3
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.85
Funders
- European Society for Medical Oncology